These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2880412)

  • 21. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal.
    Schusdziarra V; Rouiller D; Pietri A; Harris V; Zyznar E; Conlon JM; Unger RH
    Am J Physiol; 1979 Dec; 237(6):E555-60. PubMed ID: 517653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
    Roden M; Stingl H; Chandramouli V; Schumann WC; Hofer A; Landau BR; Nowotny P; Waldhäusl W; Shulman GI
    Diabetes; 2000 May; 49(5):701-7. PubMed ID: 10905476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating somatostatin after oral glucose in hypothyroidism.
    Kung AW; Lam KS; Pun KK; Wang C; Yeung RT
    J Endocrinol Invest; 1990 May; 13(5):403-6. PubMed ID: 1974268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Schneider V; Karam JH; Noacco C
    J Clin Invest; 1974 May; 53(5):1284-9. PubMed ID: 4825225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters.
    Lewis GF; Naples M; Uffelman K; Leung N; Szeto L; Adeli K
    Endocrinology; 2004 Nov; 145(11):5006-12. PubMed ID: 15271878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acetylcholine on the release of pancreatic and gastric somatostatin-like immunoreactivity in normal, chemically sympathectomized and indomethacin-treated dogs.
    Schusdziarra V; Stapelfeldt W; Klier M; Pfeiffer EF
    Hepatogastroenterology; 1982 Aug; 29(4):153-6. PubMed ID: 6127302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of somatostatin on the absorption of triglycerides in partially gastrectomized subjects.
    Hengl G; Prager J; Pointner H
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):392-5. PubMed ID: 525216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man.
    Marco J; Hedo JA; Villaneuva ML
    J Clin Endocrinol Metab; 1977 Apr; 44(4):695-8. PubMed ID: 849979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.
    Conlon JM; Srikant CB; Ipp E; Schusdziarra V; Vale W; Unger RH
    J Clin Invest; 1978 Dec; 62(6):1187-93. PubMed ID: 748373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma somatostatin 28 increases in response to feeding in man.
    Polonsky KS; Shoelson SE; Docherty HM
    J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans.
    Stingl H; Raffesberg W; Nowotny P; Waldhäusl W; Roden M
    Obes Res; 2002 Nov; 10(11):1111-9. PubMed ID: 12429874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men.
    D'Alessio DA; Ensinck JW
    Diabetes; 1990 Oct; 39(10):1198-202. PubMed ID: 1976558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of plasma free fatty acids on glucose production in the conscious dog.
    Wolfe RR; Shaw JH
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E181-6. PubMed ID: 6141738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the hormonal status of somatostatin in man.
    Zyznar ES; Pietri AO; Harris V; Unger RH
    Diabetes; 1981 Oct; 30(10):883-6. PubMed ID: 6115787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.